Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Callan JMB is a vertically integrated logistics and fulfillment company that specializes in thermal management solutions for the life sciences industry, including cold chain logistics for cell therapies, vaccines, and diagnostic materials. In early 2026, the company significantly expanded its role in the biopharmaceutical sector by entering into a strategic teaming agreement with Attune Biotech (Biostax Corp) to oversee manufacturing, quality assurance, and Strategic National Stockpile deployment for a therapeutic pipeline. This pipeline includes Lodonal, a TLR4 antagonist, and MENK-201, a peptide therapeutic with Phase 2 clinical data. Callan JMB leverages its extensive government relationships with agencies like BARDA and the Department of Defense to accelerate the commercialization and distribution of critical medical countermeasures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JMB Realty.